Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis

Annals of the Rheumatic Diseases

Volumn 62, Issue 1, 2003, Pages 27-32

  Sugiyama, S ^a   Itokazu, M ^a   Suzuki, Y ^b   Shimizu, K ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROCOLLAGEN; PROCOLLAGEN TYPE 2 PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; KNEE ARTHRITIS; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PATELLOFEMORAL JOINT; PRIORITY JOURNAL; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL; TIBIA; X RAY;

ADULT; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KNEE JOINT; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SYNOVIAL FLUID;

EID: 0037216367     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.1.27     Document Type: Article

References (32)

1. Sharif M, Saxne T, Shepstone L, Kirwan JR, Elson CJ, Heinegard D, et al. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol 1995; 34:306-10.
2. Sharif M, George E, Shepstone L, Knudson W, Thonar EJ-MA, Cushnaghan J, et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995; 38:760-7.
3. Poole AR. Cartilage in health and disease. In: Koopman WJ, ed. Arthritis and Allied Conditions: A Textbook of Rheumatology. 13th Ed. Baltimore: Williams and Wilkins, 1997:279-333.
4. Peltone L, Halila R, Ryhanen L. Enzymes converting procollagens to collagens. J Cell Biochem 1985; 28:15-21.
5. Lohmander LS, Yoshihara Y, Roos H, Kobayashi T, Yamada H, Shinmei M. Procollagen II C-propeptide in joint fluid: Changes in concentration with age, time after knee injury, and osteoarthritis. J Rheumatol 1996; 23:1765-9.
6. Shinmei M, Ito K, Matsuyama S, Yoshihara Y, Matsuzawa K. Joint fluid carboxy terminal type II procollagen peptide as a marker of cartilage biosynthesis. Osteoarthritis Cartilage 1993; 1:121-8.
7. Niyibizi C, Wu J-J, Eyre DR. The carboxypropeptide trimer of type II collagen is a prominent component of immature cartilages and intervertebral disc tissue. Biochem Biophys Acta 1987; 916:493-9.
8. Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, Ionescu M, et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998; 102:2115-25.
9. Tyler JA, Bolis S, Dingle JT, Middleton JFS. Mediators of matrix catabolism. In: Kuettner KE, Schleyerbach R, Peyron JG, Hascall VC, eds. Articular Cartilage and Osteoarthritis. New York: Raven Press, 1992:251-64.
10. Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, et al. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum 2000; 43:673-82.
11. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994; 93:1722-32.
12. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995; 96:2859-69.
13. Buckland-Wright JC. Protocols for precise radio-anatomical positioning of the tibiofemoral and patello-femoral compartments of the knee. Osteoarthritis Cartilage 1995; 3(suppl A):71-80.
14. Buckland-Wright JC, Macfarlane DG, Williams SA, Ward RJ. Accuracy and precision of joint space width measurements in standard and macro-radiographs of osteoarthritic knees. Ann Rheum Dis 1995; 54:872-80.
15. Buckland-Wright JC. Radiographic assessment of osteoarthritis: Comparison between existing methodologies. Osteoarthritis Cartilage 1999; 7:430-3.
16. Altman RD, Hochberg M, Murphy WA, Wolfe Jr F, Lequesne M. Atlas of individual rodiogrophic features in osteoarthritis. Osteoarthritis Cartilage 1995; 3(suppl A):3-70.
17. SAS Inslitute. SAS/STAT User's Guide, Version 6.04. Cary, NC: SAS Institute, 1989.
18. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al. Low level increases in serum C reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997; 40:723-7.
19. Fawthrop F, Yaqub R, Belcher C, Bayliss M, Ledingham J, Doherty M. Chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis. Ann Rheum Dis 1997; 56:119-22.
20. Lohmander LS. Osteoarthritis: Man models and molecular markers. In: Maroudas A, Kuettner K, eds. Methods in Cartilage Research. London: Academic Press, 1990:337-40.
21. Mazzuca SA, Brandt KD, Kotz BP. Is conventional radiography suitable for evaluation of a disease-modifying drug in patients with knee osteoarthritis? Osteoarthritis Cartilage 1997; 5:217-26.
22. Dieppe PA, Cushnaghan J, Shepstone L. The Bristol 'OA500' study: Progression of osteoarthritis (OA) over 3 years and the relationship between clinical and radiographic changes at the knee joint. Osteoarthritis Cartilage 1997; 5:87-97.
23. Neuhauser KB, Anderson JJ, Felson DT. Rate of joint space narrowing in normal knees and knees with osteoarthritis. Arthritis Rheum 1994; 37(suppl 9):S423.
24. Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995; 38:1134-41.
25. Dougados M, Gueguen A, Nguyen M, Thiesce A, Listrat V, Jacob L, et al. Longitudinal radiologic evaluation of osteoarthritis of the knee. J Rheumatol 1992; 19:378-84.
26. Schouten JSAG, van den Ouweland FA, Valkenburg HA. A 12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee. Ann Rheum Dis 1992; 51:932-7.
27. Cooper C, McAlindon TE, Coggon D, Egger P, Dieppe PA. Occupational activity and osteoarthritis of the knee. Ann Rheum Dis 1994; 53:90-3.
28. Kobayashi T, Yoshihara Y, Samura A, Yamada H, Shinmei M, Roos H, et al. Synovial fluid concentrations of the C propeptide of type II collagen correlate with body mass index in primary knee osteoarthritis. Ann Rheum Dis 1997; 56:500-3.
29. Kempson GE, Muir H, Pollard C, Tuke M. The tensile properties of the cartilage of human femoral candyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta 1973; 297:465-72.
30. Stoop R, van der Kraan PM, Buma P, Hollander AP, Billinghurst RC, Poole AR, et al. Type II collagen degradation in spontaneous osteoarthritis in C57BI/6 and BALB/c mice. Arthritis Rheum 1999; 42:2381-9.
31. Shinmei M, Kobayashi T, Yoshihara Y, Samura A. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid. J Rheumatol 1995; 22(suppl 43):78-81.
32. Fife RS, Brandt KD, Braunstein EM, et al. Relationship between arthroscopic evidence of cartilage damage and radiographic evidence of joint space narrowing in early osteoarthritis of the knee. Arthritis Rheum 1991; 34:377-81.